Midgard Science

Labs / Protein production

Imunexus Therapeutics

Bundoora, Australia · imunexus.com

On your own

Free. Their own form.

Contact Imunexus Therapeutics directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Imunexus Therapeutics Ltd is an Australian biotechnology company developing multispecific biologic medicines for serious diseases. Its lead program, IMX39, is being developed for multiple sclerosis, and its pipeline also spans oncology, rare disease, and regenerative medicine.

They take quote requests by email.

What they offer

  • Imunexin™ platform development

    Develops a patented platform that adds engineered protein modules to existing biologic drugs to create multispecific therapies.

  • Multispecific biologic drug development

    Develops next-generation biologic medicines designed to act on multiple biological pathways within a single therapy.

  • Strategic biologics partnerships

    Supports collaborations to enhance existing biologic drugs using the imunexin™ platform.

What they work on

Modalities
Antibody, Bispecific, Peptide, Cell therapy, Recombinant protein
Therapeutic areas
multiple sclerosis, neurology, oncology, rare disease, regenerative medicine, small cell lung cancer, Gaucher’s disease
Sites
Bundoora, Australia

Similar labs. Abnova, Myriotx, Oncodesign Services, ORF Biologics

Found in a contract services directory. Listing built from imunexus.com. Work here? Claim this listing.

Imunexus Therapeutics · Midgard Science